Please use this identifier to cite or link to this item: http://hdl.handle.net/11718/20486
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGupta, Anil K.
dc.date.accessioned2018-03-07T04:31:08Z
dc.date.available2018-03-07T04:31:08Z
dc.date.issued1998-12-01
dc.identifier.urihttp://hdl.handle.net/11718/20486
dc.description.abstractIn this paper, I first discuss the key concept of IPR and its relevance for our conditions. I particularly refer to the opportunities that exist globally with specific reference to patent expiration, biodiversity based drug development. I also review the recent trends in filing patents based on herbal resources in US Patent Office during last two years compared to the trends apparent in 1992. In part two I review the inter-organisational strategies for R&D drawing upon the excellence in informal sector as well as formal sector. Finally, I summaries the strategy that Indian pharmaceutical industry could pursue for global competitive advantage through protection of IPRs without compromising on the goal of universal health for all.en_US
dc.language.isoen_USen_US
dc.publisherIndian Institute of Management Ahmedabaden_US
dc.relation.ispartofseriesWP;1494
dc.subjectDrug industry- Indiaen_US
dc.subjectIntellectual property rightsen_US
dc.titleStrategic opportunities in managing IPRs: Biodiversity, drug industry and emerging optionsen_US
dc.typeWorking Paperen_US
Appears in Collections:Working Papers

Files in This Item:
File Description SizeFormat 
wp 1998_1494.pdfWP_1998_1494985.24 kBAdobe PDFView/Open


Items in IIMA Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated.